References
Adebamowo, C., O. Bah-Sow, F. Binka, et al. 2014. Randomised controlled trials for Ebola: Practical and ethical issues. The Lancet 384(9952): 1423–1424.
Folayan, M., B. Brown, A. Yakubu, K. Peterson, and B. Haire. 2014. Compassionate use of experimental drugs in the Ebola outbreak. The Lancet 384(9957): 1843–1844.
Hossain, M.J., A. Roca, G.A. Mackenzie, et al. 2013. Serogroup W135 meningococcal disease, The Gambia, 2012. Emerging Infectious Diseases 19(9): 1507–1510.
Kanapathipillai, R., A.M.H. Restrepo, P. Fast, et al. 2014. Ebola vaccine—an urgent international priority. The New England Journal of Medicine 371(24): 2249–2251. doi:10.1056/NEJMp1412166.
Lenzer, J. 2006. Secret report surfaces showing that Pfizer was at fault in Nigerian drug tests. BMJ 332(7552): 1233.
Lenzer, J. 2011. Pfizer settles with victims of Nigerian drug trial. BMJ 343: d5268. doi:10.1136/bmj.d5268.
Maurice, J. 2014. WHO meeting chooses untried interventions to defeat Ebola. The Lancet 384(9948): e45–e46.
Omonzejele, P.F. 2014. Ethical challenges posed by the Ebola virus epidemic in West Africa. Journal of Bioethical Inquiry 11(4): 417–420.
Rid, A., and E.J. Emanuel. 2014. Ethical considerations of experimental interventions in the Ebola outbreak. The Lancet 384(9957): 1896–1899.
World Health Organization [WHO]. 2014. Potential Ebola therapies and vaccines. World Health Organization, November 5. http://apps.who.int/iris/bitstream/10665/137590/1/WHO_EVD_HIS_EMP_14.1_eng.pdf?ua=1. Accessed November 16, 2014.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Afolabi, M.O. Situating the Trovan Trial With the Use of Experimental Ebola Therapies Is Like Comparing an Apple With an Orange. Bioethical Inquiry 12, 19–20 (2015). https://doi.org/10.1007/s11673-015-9619-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11673-015-9619-7